Recent studies have shown that eIF3a was highly expressed in esophageal squamous cell carcinoma (ESCC), colorectal cancer and thyroid cancer (TC) [16–18], but lower in clear cell renal cell carcinoma (ccRCC) [24]. Here, EIF3A is linked to thyroid cancer.